Prosecution Insights
Last updated: August 18, 2026

Examiner: LEWIS, PATRICK T

Tech Center 1600 • Art Units: 1621 1623 1657 1672 1673 1691 1693

This examiner grants 74% of resolved cases

Performance Statistics

74.2%
Allow Rate
+14.2% vs TC avg
1,181
Total Applications
+14.2%
Interview Lift
845
Avg Prosecution Days
Based on 1162 resolved cases, 2023–2026

Rejection Statute Breakdown

6.2%
§101 Eligibility
19.7%
§102 Novelty
31.7%
§103 Obviousness
22.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18609391 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF Non-Final OA The Regents of the University of Michigan
18597050 COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2 Non-Final OA RENSSELAER POLYTECHNIC INSTITUTE
18279687 Synthesis of Gamma Peptide Nucleic Acid Monomers and Oligomers, and Applications Therefor Non-Final OA Carnegie Mellon University
18294477 5'UTR VARIANT SEQUENCE OF GENE ENCODING PHOSPHOENOLPYRUVATE CARBOXYLASE, AND USES THEREOF Non-Final OA CJ CHEILJEDANG CORPORATION
18510836 PHARMACEUTICAL COMBINATIONS AND USES THEREOF Non-Final OA NOVARTIS AG
18685385 TRANSPARENT COMPOSITION COMPRISING POLYHYDROXY ACID Non-Final OA L'OREAL

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month